We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Immunoassay Analyzer Introduced at 2016 AACC Annual Meeting

By LabMedica International staff writers
Posted on 12 Aug 2016
Print article
Image: The Atellica Solution, a highly flexible immunoassay and clinical chemistry analyzer (Photo courtesy of Siemens Healthineers).
Image: The Atellica Solution, a highly flexible immunoassay and clinical chemistry analyzer (Photo courtesy of Siemens Healthineers).
The recently renamed medical instrument manufacturer Siemens Healthineers (Erlangen, Germany) chose the July 31 - August 4, 2016, AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA) as the venue for introducing its new Atellica Solution automated immunoassay and clinical chemical analyzer system.

In May 2016, Siemens Healthcare changed its name to Healthineers, a name that embodied the company’s pioneering spirit and engineering expertise in the healthcare industry. It is unique and bold name and gives a new identity to the organization and to its employees who serve and inspire healthcare providers worldwide.

One of Healthineers' dynamic new products is the Atellica Solution. This highly flexible immunoassay and clinical chemistry solution features patented bi-directional magnetic sample-transport technology that allows the system to operate 10 faster than conventional conveyors. The platform boasts a multi-camera vision system and intelligent sample routing that allows independent control over every sample from routine assays to STATs.

Atellica Solution, which can handle more than 30 sample container types including pediatric and special containers, can be used as a stand- alone instrument, or it can be scaled up to 10 components with more than 300 customizable configurations. The system supports remote-access monitoring and control, which maximizes instrument uptime, with a broad and expanding assay menu using proven detection technologies.

"We engineered the Atellica Solution based on our customers' needs and extensive research of market trends," said Franz Walt, president of laboratory diagnostics at Siemens Healthineers. "The result is a game-changer that delivers control and simplicity, so our customers can focus on driving better business and clinical outcomes and spend less time managing operations."

The Atellica Solution is currently being evaluated by the Food and Drug Administration and is not yet available in the United States.

Related Links:
Siemens Healthineers
AACC Annual Meeting & Clinical Lab Expo
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Histamine ELISA
Histamine ELISA
New
PSA Test
Human Semen Rapid Test

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.